VALIDATION IMAGES
Lane 1: Human placenta cells lysates; Lane 2: Jurkat cells lysates; Line 3: A431 cells lysates ;Probed with Ezrin (7C2) Monoclonal Antibody (bsm-52900R) at 1:1000 overnight at 4°C followed by a conjugated secondary antibody for 60 minutes at 37°C.
Paraformaldehyde-fixed and paraffin-embedded Human breast carcinoma tissue incubated with Ezrin (7C2) Monoclonal Antibody (bsm-52900R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Paraformaldehyde-fixed and paraffin-embedded Human colon cancer tissue incubated with Ezrin (7C2) Monoclonal Antibody (bsm-52900R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Paraformaldehyde-fixed and paraffin-embedded Human kidney tissue incubated with Ezrin (7C2) Monoclonal Antibody (bsm-52900R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Paraformaldehyde-fixed and paraffin-embedded Human liver cancer tissue incubated with Ezrin (7C2) Monoclonal Antibody (bsm-52900R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Paraformaldehyde-fixed and paraffin-embedded Human lung cancer tissue incubated with Ezrin (7C2) Monoclonal Antibody (bsm-52900R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Paraformaldehyde-fixed and paraffin-embedded Human lung tissue incubated with Ezrin (7C2) Monoclonal Antibody (bsm-52900R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.